Sales and Marketing

Showing 15 posts of 11524 posts found.

Generics firm press for ‘clear and open’ market

February 8, 2010 Sales and Marketing generics, industry

Generic drug companies have set out their vision of a more ‘clear’ and ‘open’ market in Europe. Greg Perry, director …

GSK appoints Philippe Fauchet president of GSK Japan

February 8, 2010 Sales and Marketing GlaxoSmithKline, appointment, sales and marketing

GSK has appointed Philippe Fauchet president of GSK Japan, reporting to to Marc Dunoyer who takes a new role as …
UK swine flu leaflet

UK swine flu cases fall

February 5, 2010 Sales and Marketing h1n1, swine flu

The government has warned against complacency over swine flu as it released figures showing UK cases had fallen to one …
ABPI

Barker praises OLS model

February 5, 2010 Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …
Andrew Witty

GSK confirms job cuts but avoids specifics

February 5, 2010 Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline

GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …

Portfolio Harmony in five easy steps

February 5, 2010 Sales and Marketing product portfolio

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …

Zeftera problems weigh down Basilea

February 5, 2010 Sales and Marketing 2009 financials, Basilea, Zeftera

Specialist Swiss pharma company Basilea has announced a doubling of its revenues in 2009, thanks to the launch of its …
Pfizer World

Wyeth acquisition yet to shake Pfizer’s Lipitor dependence

February 4, 2010 Sales and Marketing 2009 financials, Lipitor, Pfizer

Pfizer’s profits rose by 7% last year on the back of a 4% increase in revenue driven by cholesterol treatment …

Oxford Immunotec appoints Frank Vandeputte

February 4, 2010 Sales and Marketing Oxford Immunotec, appointment, medical devices, sales and marketing

Medical diagnostics company Oxford Immunotec has appointed Frank Vandeputte vice president, sales and marketing. He was formerly VP, Europe for …

Digital Pharma: New EMA website previewed

February 3, 2010 Research and Development, Sales and Marketing EMA, branding, digital pharma

The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information. This …

FDA to assess Neupogen biosimilar

February 3, 2010 Research and Development, Sales and Marketing Hospira, Teva, biosimilars

US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …
Roche building

Genentech integration hits Roche profits

February 3, 2010 Sales and Marketing 2009 financials, Genentech, Roche

Roche achieved healthy sales growth in 2009 but saw a 22% drop in net income due to the cost gaining …

Brennan maintains support for US reforms

February 2, 2010 Sales and Marketing Obama, US healthcare

David Brennan has reiterated the industry’s early support for President Obama’s healthcare plans, but acknowledged the recent election of a …

Novo buoyed by insulin portfolio

February 2, 2010 Sales and Marketing 2009 financials, Novo Nordisk, Victoza

Danish pharma company Novo Nordisk managed a double-digit rise in sales and profits in 2009, buoyed by insulin products NovoRapid, …

Job cuts at GlaxoSmithKline and AstraZeneca

February 2, 2010 Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline

Britain’s two biggest pharma companies GlaxoSmithKline and AstraZeneca are poised to make deep job cuts as business models continue to …
The Gateway to Local Adoption Series

Latest content